FDA Commissioner Marty Makary defends the agency's recent rejection of rare disease drugs. The agency's top official Vinay Prasad comments on the topic. The article also mentions a case with an alleged "smear campaign" against the FDA. Cigna buys a big pharmacy, another major pharma development. These reports are part of the review of current health news in the Pharmalittle section.[1]